Deadly fever the first target for revolutionary startup

It’s often a good idea for startup founders to have a close familiarity with their product. For one scientist, contracting the tropical disease for which he’s attempting to provide a revolutionary diagnosis was not part of the plan.

GlowDX was founded by Honduras native Yensi Flores and her two Irish colleagues, Blaine Doyle and Aisling Finn. It set out to tackle a scourge of the developing world by making cheap and reliable tropical disease diagnostics available to people worldwide.

First on the biotech company’s hitlist is dengue fever which is carried by mosquitos and affects an estimated 100m people every year.